1-2 of 2
Guillaume Olombel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Isatuximab, Pomalidomide and Dexamethasone in Relapsed AL Amyloidosis: Interim Results of the Isamyp Phase 2 Joint Study from the IFM and ALLG

Peter Mollee, Antoine Huart, Olga Mortona, Kentin Queru, Cecile Leyronnas, Harel Stephanie, Hasib Sidiqi, Estelle Desport, Laure Vincent, Margaret Macro, Salomon Manier, Caroline Jacquet, Pierre Morel, Noemi Horvath, Sebastien Bender, Guillaume Olombel, Virginie Pascal, Jill Corre, Frank Bridoux, Arnaud Jaccard, Murielle Roussel
Journal: Blood
Blood (2024) 144 (Supplement 1): 892.
https://doi.org/10.1182/blood-2024-204700
Published: 2024
Journal Articles

The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia

Clinical Trials & Observations
Guillaume Olombel, Estelle Guerin, Julien Guy, Jean-Yves Perrot, Florent Dumezy, Adrienne de Labarthe, Jean-Noël Bastie, Ollivier Legrand, Emmanuel Raffoux, Adriana Plesa, Orianne Wagner-Ballon, Edouard Cornet, Véronique Salaun, Claude Preudhomme, Xavier Thomas, Cécile Pautas, Sylvain Chantepie, Pascal Turlure, Sylvie Castaigne, Hervé Dombret, Jean Feuillard
Journal: Blood
Blood (2016) 127 (17): 2157–2160.
https://doi.org/10.1182/blood-2016-01-689976
Published: 2016
Includes: Supplemental data